SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
4.9 based on 1,805 reviews
fsaAccept major insurances and cash-pay
Back

Blog Archives

Published: Jul 10, 2026

Share

Does BlueCross BlueShield of Mississippi Cover Anxiety Treatment? A 2026 Guide

Share

Written by Klarity Editorial Team

Published: Jul 10, 2026

Does BlueCross BlueShield of Mississippi Cover Anxiety Treatment? A 2026 Guide
Table of contents
Share

Last updated: July 10, 2026

Anxiety disorders affect more than 40 million adults in the United States, yet navigating insurance coverage for anxiety treatment can feel overwhelming. If you have a BlueCross BlueShield of Mississippi (BCBS MS) health plan, this guide explains how the insurer’s internal be RxSmart pharmacy program typically handles anxiety medications, what prior authorization requirements may apply, how Mississippi parity law protects you, and how Klarity Health’s licensed providers may be able to help you access care.

Coverage varies by individual plan. Always verify your specific benefits with BCBS MS before scheduling an appointment.

Ready to explore anxiety treatment options?
Klarity Health connects you with licensed providers who accept many insurance plans. Check if your BCBS MS plan may cover anxiety care →

Understanding BlueCross BlueShield of Mississippi

BlueCross BlueShield of Mississippi is an independent licensee of the Blue Cross and Blue Shield Association. Unlike many BCBS affiliates in other states, BCBS MS operates its own internal pharmacy program called be RxSmart, with a Mississippi-licensed Pharmacy and Therapeutics (P&T) Committee that conducts quarterly formulary reviews. Industry claims routing data classifies BCBS MS as “Non Prime,” meaning it does not route through Prime Therapeutics (the PBM used by most other BCBS affiliates).

BCBS MS Plan Types

  • Commercial PPO — The primary plan type for individual and group commercial members. Uses the be RxSmart formulary.
  • ACA Marketplace (Qualified Health Plan) — Individual and family plans purchased through the federal marketplace. Uses be RxSmart formulary.
  • Federal Employee Program (FEP / Blue Cross and Blue Shield Service Benefit Plan) — Federal government employees covered through OPM. Has its own FEP formulary, separate from be RxSmart.
  • State and School Employees’ Health Insurance Plan — Mississippi state government and public school employees are administered by BCBS MS, but this plan uses CVS Caremark as its PBM — a distinct formulary from commercial be RxSmart members. If you are a state/school employee, verify which formulary applies to your specific plan documents.

This guide focuses on commercial PPO and ACA Marketplace plans using the be RxSmart formulary. FEP and state employee members should consult their separate plan documents.

The be RxSmart Formulary: How It Works

BCBS MS organizes covered medications into four cost categories under the be RxSmart program:

  • Category 1 — Low-cost generic drugs. Typically the lowest copay tier.
  • Category 2 — Higher-cost generics and some brand medications. Moderate copay.
  • Category 3 — Select brand medications. Higher copay; often requires a prior generic trial.
  • Category 4 — High-cost or specialty medications. Highest cost-sharing tier.
  • Disease-Specific — Specialty drugs for complex conditions; coinsurance typically at Category 4 rate or 10% up to $200 per fill.

Generic First (Step Therapy) Policy: be RxSmart applies a Generic First policy across most drug classes. This means BCBS MS typically requires members to try and fail a lower-cost generic equivalent before authorizing coverage of a brand-name medication. For anxiety treatment, this most commonly affects brand-name SSRIs and SNRIs — nearly all first-line anxiety medications have low-cost generic alternatives available, so step therapy is unlikely to delay initial treatment for most patients.

Anxiety Medications: Typical be RxSmart Coverage

The following tables reflect how BCBS MS’s be RxSmart formulary may typically handle anxiety medications as of mid-2026. Tier placements and PA requirements are subject to quarterly P&T Committee review — verify current tier status via the be RxSmart drug search at bcbsms.com or by calling member services at 800-942-0278.

SSRIs (Selective Serotonin Reuptake Inhibitors) — First-Line for Anxiety

All SSRIs are non-scheduled (no DEA controlled substance designation). No EPCS requirement applies.

MedicationGeneric Namebe RxSmart CategoryPrior Auth?Notes
Sertraline (Zoloft generic)Sertraline HClCategory 1NoMost commonly prescribed SSRI for anxiety; very low cost-share
Escitalopram (Lexapro generic)Escitalopram oxalateCategory 1NoWidely used for GAD and social anxiety; preferred formulary position
Fluoxetine (Prozac generic)Fluoxetine HClCategory 1NoApproved for panic disorder and OCD; long half-life reduces missed-dose sensitivity
Paroxetine (Paxil generic)Paroxetine HClCategory 1–2NoFDA-approved for GAD, panic, social anxiety, PTSD; generic widely available
Citalopram (Celexa generic)Citalopram HBrCategory 1NoOff-label use for panic and anxiety; preferred as generic
Lexapro (brand)EscitalopramCategory 3Step therapyBrand requires prior generic escitalopram trial under Generic First policy

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) — Second-Line / Dual Anxiety-Depression

All SNRIs are non-scheduled. No EPCS requirement applies.

MedicationGeneric Namebe RxSmart CategoryPrior Auth?Notes
Venlafaxine ER (Effexor XR generic)Venlafaxine HCl ERCategory 1–2NoFDA-approved for GAD, social anxiety, and panic disorder; taper required on discontinuation
Duloxetine (Cymbalta generic)Duloxetine HClCategory 1–2NoFDA-approved for GAD; also covers comorbid pain conditions
Desvenlafaxine (Pristiq generic)Desvenlafaxine succinateCategory 2–3Step therapyMay require venlafaxine ER trial first under step therapy protocol

Non-Controlled Anxiolytics — Non-Habit Forming Alternatives

Buspirone and hydroxyzine are non-scheduled with no abuse potential. No EPCS requirement applies.

MedicationGeneric Namebe RxSmart CategoryPrior Auth?Notes
Buspirone (Buspar generic)Buspirone HClCategory 1NoNon-habit-forming; preferred for long-term GAD management; no sedation, no dependence risk
Hydroxyzine (Vistaril/Atarax generic)Hydroxyzine HCl / PamoateCategory 1NoNon-controlled antihistamine anxiolytic; useful for situational anxiety and PRN dosing

Benzodiazepines — Schedule IV (Short-Term / As-Needed Use)

Benzodiazepines are DEA Schedule IV controlled substances — a lower classification than Schedule II. Mississippi’s EPCS statute (Miss. Code Ann. § 41-29-137) applies only to Schedule II substances. Benzodiazepines are entirely exempt from EPCS requirements — they may be prescribed electronically or on paper at the provider’s discretion.

MedicationGeneric Namebe RxSmart CategoryPrior Auth?Notes
Alprazolam (Xanax generic)AlprazolamCategory 2Quantity limitsSchedule IV; quantity limits apply; short-term/PRN use; generic widely covered
Clonazepam (Klonopin generic)ClonazepamCategory 2Quantity limitsSchedule IV; longer half-life than alprazolam; FDA-approved for panic disorder
Lorazepam (Ativan generic)LorazepamCategory 2Quantity limitsSchedule IV; intermediate half-life; common for situational/procedural anxiety
Diazepam (Valium generic)DiazepamCategory 2Quantity limitsSchedule IV; long half-life; less commonly prescribed for primary anxiety management

Benzo quantity limits: be RxSmart typically applies quantity limits to benzodiazepines (e.g., a 30-day supply cap, or daily dosage limits). Long-term use beyond 90 days may require a prior authorization review. Your BCBS MS plan documents will specify exact quantity limit parameters.

Prior Authorization: What to Expect

Most first-line generic anxiety medications (SSRIs, SNRIs at Category 1–2, buspirone, hydroxyzine) do not require prior authorization under be RxSmart. PA is most likely to be required in these scenarios:

  • Brand-name SSRIs/SNRIs after generic step therapy requirement (e.g., Lexapro brand after generic escitalopram)
  • Desvenlafaxine when venlafaxine ER has not been tried first
  • Long-term benzodiazepine use beyond the initial quantity limit window
  • Non-formulary medications that fall outside standard be RxSmart covered tiers

How to Submit a Prior Authorization Through be RxSmart

  1. Your Klarity provider initiates the PA request through the myBlue Provider portal or by contacting the be RxSmart PA team at BCBS MS.
  2. BCBS MS receives and reviews the clinical documentation — typically diagnosis codes, prior medication history, and clinical notes supporting medical necessity.
  3. PA decision issued — standard PA decisions are typically issued within 3 business days. Urgent/expedited cases may be resolved within 24–72 hours.
  4. Approval or denial communicated — you and your provider receive written notification. If approved, the medication is covered at the applicable tier.
  5. If denied: initiate the appeals process (see Appeals section below).

EPCS and Telehealth Prescribing: A Simple Story for Anxiety

Mississippi’s Electronic Prescribing for Controlled Substances (EPCS) statute — Miss. Code Ann. § 41-29-137 — mandates electronic prescribing only for Schedule II controlled substances. No anxiety medication used by Klarity providers is a Schedule II drug.

  • SSRIs and SNRIs — non-scheduled (no DEA classification). EPCS entirely inapplicable.
  • Buspirone and hydroxyzine — non-scheduled. EPCS entirely inapplicable.
  • Benzodiazepines — DEA Schedule IV. Schedule IV is exempt from EPCS requirements. Providers may prescribe electronically or by paper prescription at their clinical discretion.

This means Klarity’s telehealth providers face no EPCS-related barrier when prescribing anxiety medications to Mississippi BCBS MS members. Initial consultations, prescription refills, and follow-up care can all occur via telehealth without the prescribing workflow limitations that apply to Schedule II medications (such as ADHD stimulants).

Mississippi Mental Health Parity Law and Your Rights

Mississippi’s Mental Health Parity and Insurance Reform Act — Miss. Code Ann. § 83-9-353 et seq. — requires that health insurance policies regulated by the Mississippi Insurance Department provide mental health and substance use disorder benefits on terms no more restrictive than comparable medical-surgical benefits. Anxiety disorders are recognized mental health conditions covered under this parity mandate.

Practically, this means BCBS MS may not:

  • Impose higher cost-sharing (copays, deductibles, coinsurance) for anxiety treatment than for comparable medical conditions
  • Apply more restrictive treatment limitation days or visit limits for mental health care than for medical care
  • Use stricter prior authorization criteria for mental health medications than for other drug classes at the same formulary tier

Federal MHPAEA Protection

The federal Mental Health Parity and Addiction Equity Act (MHPAEA) — reinforced by the 2024 MHPAEA final rule — adds a second layer of parity protection for employer-sponsored group health plans. MHPAEA prohibits group health plans from applying quantitative or non-quantitative treatment limitations to mental health benefits that are more restrictive than those applied to medical-surgical benefits in the same classification.

ERISA Carve-Out for Self-Funded Employer Plans

Mississippi state parity law applies to fully-insured health insurance policies regulated by the MS Insurance Department. If your employer is self-funded (self-insured), your plan is governed by ERISA federal law rather than Mississippi state statutes. Self-funded plans are not subject to Miss. Code Ann. § 83-9-353, but they remain subject to MHPAEA. Check your Summary Plan Description (SPD) to determine whether your plan is fully-insured or self-funded.

How to Get Anxiety Treatment Through Klarity Health with BCBS MS

  1. Check your benefits — Confirm mental health and prescription drug benefits are active on your BCBS MS plan by calling member services at 800-942-0278 or logging in at bcbsms.com. Ask specifically whether your plan requires a referral for telehealth mental health services.
  2. Schedule your Klarity appointment — Klarity’s network of 2,000+ licensed providers includes psychiatrists, psychiatric nurse practitioners, and licensed therapists who may be in-network with BCBS MS commercial plans. Visit helloklarity.com to find a provider and book.
  3. Your provider conducts your evaluation — During a telehealth visit, your Klarity provider will assess your anxiety symptoms, review your medical history, and discuss treatment options including medication and therapy.
  4. Prescription sent to your pharmacy — If medication is appropriate, your provider sends the prescription electronically to your preferred pharmacy. For SSRIs, SNRIs, buspirone, and hydroxyzine, no special prescribing workflow is required. For benzodiazepines (Schedule IV), standard pharmacy procedures apply.
  5. Ongoing care and refills — Klarity supports ongoing follow-up visits to monitor treatment response, adjust medications if needed, and manage refills — all via telehealth without requiring in-person office visits.
See if your BCBS MS plan may cover anxiety treatment at Klarity.
Verify your benefits and find a provider →

Mississippi Medicaid Note

Klarity Health does not currently accept Mississippi Medicaid (Division of Medicaid / MS DOM). This guide applies to BCBS MS commercial, ACA Marketplace, and FEP members only. Mississippi Medicaid members should contact the MS Division of Medicaid at 1-800-421-2408 or visit medicaid.ms.gov to identify participating mental health providers.

What If BCBS MS Denies Coverage?

If your BCBS MS claim or prior authorization for anxiety medication or treatment is denied, you have the right to appeal. The standard appeals pathway for BCBS MS fully-insured commercial plans is:

  1. Internal Appeal — Submit a written appeal to BCBS MS within the timeframe specified in your denial letter (typically 180 days). Include supporting clinical documentation from your provider. Internal appeals are reviewed by BCBS MS medical staff not involved in the original decision.
  2. External Independent Review — If the internal appeal is denied, you may request an External Independent Review by a third-party Independent Review Organization (IRO) certified by the Mississippi Insurance Department.
  3. Mississippi Insurance Department Complaint — If you believe your parity rights have been violated, file a complaint with the MS Insurance Department at 1-800-562-2957 or visit mid.ms.gov. The MID has authority to investigate MHPAEA parity violations for fully-insured plans.
  4. ERISA / DOL Complaint — For self-funded employer plans, contact the U.S. Department of Labor at 1-866-444-3272 or dol.gov/agencies/ebsa to report potential MHPAEA violations.

Frequently Asked Questions

Does BCBS MS cover online anxiety therapy and medication management?

Many BCBS MS commercial plans include telehealth coverage for mental health services, including psychiatric evaluation and medication management for anxiety disorders. However, telehealth benefits vary by specific plan. Check your Summary of Benefits and Coverage (SBC) or call 800-942-0278 to confirm telehealth mental health coverage on your plan.

Do I need a referral to see a Klarity anxiety provider with BCBS MS?

BCBS MS PPO plans generally do not require a referral to see a mental health specialist. HMO-style plans may require a referral from your primary care physician. Review your plan type and consult your member ID card or member portal to confirm whether a referral is needed before your appointment.

Are anxiety medications considered controlled substances?

Most first-line anxiety medications are not controlled substances. SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), buspirone, and hydroxyzine have no DEA scheduling and are not controlled substances. Benzodiazepines (alprazolam, clonazepam, lorazepam) are DEA Schedule IV — a low-risk controlled substance classification with appropriate monitoring but none of the prescribing restrictions associated with Schedule II drugs like ADHD stimulants.

Does Mississippi’s EPCS law affect my anxiety prescription?

No. Mississippi’s EPCS requirement (Miss. Code Ann. § 41-29-137) applies only to Schedule II controlled substances. No anxiety medication — including benzodiazepines (Schedule IV) — is a Schedule II drug. Your Klarity provider can prescribe anxiety medications through standard telehealth workflows without any EPCS-specific requirements.

What is the Generic First policy and will it delay my treatment?

BCBS MS’s be RxSmart Generic First policy requires trying a generic medication before a brand-name equivalent. For anxiety treatment, this is rarely a barrier: nearly every first-line anxiety medication — sertraline, escitalopram, fluoxetine, venlafaxine ER, duloxetine, buspirone — is available as a low-cost generic at Category 1. Step therapy is most likely to affect brand-name requests (e.g., Lexapro brand when the generic escitalopram is equally effective). If you have a clinical reason to use a specific brand, your provider can submit documentation supporting a step therapy exception.

Why does BCBS MS limit the quantity of benzodiazepines?

Quantity limits on benzodiazepines reflect clinical guidelines recommending short-term or as-needed (PRN) use due to the potential for dependence with long-term daily dosing. These limits are applied consistently across commercial plans and are not specific to BCBS MS. For patients with a clinical need for ongoing benzo use (e.g., panic disorder with frequent breakthrough episodes), your provider can submit a prior authorization with supporting documentation to request a quantity limit exception.

What can I do if my BCBS MS plan denies anxiety medication coverage?

Submit a written internal appeal to BCBS MS with supporting documentation from your provider. If denied, request an External Independent Review through the Mississippi Insurance Department’s IRO process. If you suspect a parity violation, file a complaint with the MS Insurance Department (1-800-562-2957) or the DOL (1-866-444-3272) for ERISA self-funded plans.

Is Klarity Health affiliated with BlueCross BlueShield of Mississippi?

No. Klarity Health is not affiliated with, endorsed by, or in any way connected to BlueCross BlueShield of Mississippi, the Blue Cross and Blue Shield Association, or any BCBS subsidiary or licensee. This guide is provided as independent educational information to help patients understand their insurance benefits. Coverage determinations are made solely by BCBS MS according to your specific plan terms.

Contact Information

  • BCBS MS Member Services: 601-664-4590 (local) or 800-942-0278 (toll-free)
  • BCBS MS Address: 3545 Lakeland Drive, Flowood, MS 39232-9799
  • BCBS MS Member Portal: bcbsms.com
  • Mississippi Insurance Department: 1-800-562-2957 | mid.ms.gov
  • Mississippi Division of Medicaid: 1-800-421-2408 | medicaid.ms.gov
  • U.S. Department of Labor (ERISA/MHPAEA): 1-866-444-3272 | dol.gov/agencies/ebsa
Take the next step toward anxiety relief.
Klarity Health’s 2,000+ licensed providers offer telehealth anxiety evaluations and medication management. See if your BCBS MS plan may cover your care →

Disclaimer: This page is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage determinations are made by BlueCross BlueShield of Mississippi based on your individual plan terms. Always verify your benefits before scheduling care. Klarity Health is not affiliated with BlueCross BlueShield of Mississippi, the Blue Cross and Blue Shield Association, or any BCBS entity.

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.